Speakers

CONFIRMED SPEAKERS INCLUDE:

Dr. Joerg Dreyhsig

VP Associate General Counsel IP
Fresenius Medical Care AG & Co. KGaA

Sascha Roeder

IP Manager
PARI Pharma GmbH

Karine Crepin

Global Head of Biologics Patents
Sanofi Global IP Department

Emilie Frugier

Patent Manager
NBE Therapeutics AG

Dr. Oliver Werner

Head of SPC Working Group
German Patent Trade Mark Office

Stella Fletcher

Head of IP
BIAL – Portela

Paul Inman

Partner
Gowling WLG

Christoph Rehfuess

Head of IP
Sotio

Fredrik Fredh

European Patent Attorney
Novartis Pharma AG

Dr Philipp Cepl

Partner
DLA Piper

Julia Florence

Assistant General Counsel (Patents)
GlaxoSmithKline

Simon Llewellyn

Senior Associate
Carpmaels & Ransford

Frank Landolt

V.P IP
Ablynx N.V.

Marjan Noor

Partner
Allen & Overy

Guido Pontremoli

Corporate IP Patent Director
Chiesi Farmaceutici

Jon Singer

Principle
Fish & Richardson

Corinna Sundermann

Senior Vice President IP Management
Fresenius Kabi Deutschland GmbH

Ms Kene Gallois

Head of Life Science
Daniel Legal & IP Strategy

Robin Ellis

Head of IP Product Development & Strategy
Sandoz

James Velema

Partner
Lathrop Gage LLP

Azadeh Mehrabi

Strategic Intellectual Property Manager
Biotronik

Dr. Ulrich Storz

Senior Partner
Michalski Hüttermann & Partner Patentanwälte mbB

Rob Aerts

IP Director
Tigenix SAU

Sam Granata

Judge
Antwerp Court of Appeal

Nicolas Ruiz

Head of IP
Esteve

John D. Murnane

Partner
Fitzpatrick, Cella, Harper & Scinto

Arvid van Oorschot

Partner
Vondst Advocaten N.V.

Otto Swens

Partner
Vondst Advocaten N.V.

Dr Dieter Tzschoppe

Director,Healthcare,
Biotechnology and
Chemistry
European Patent Office

Vladislav Ugryumov

Partner
Gowling WLG

Ha Kung Wong

Partner
Fitzpatrick, Cella, Harper & Scinto

Scott Reed

Partner
Fitzpatrick, Cella, Harper & Scinto

Mathilde Rauline

European Patent Attorney
August-Debouzy

Richie Paul

Vice President, Intellectual Property Operations
Alkermes Pharma Ireland Limited